ORIGINAL RESEARCH article
Front. Physiol.
Sec. Clinical and Translational Physiology
This article is part of the Research TopicPhysiological and Pathological Responses to Hypoxia and High Altitude, Volume IIIView all 18 articles
Analysis of Hub Genes Temporal Dynamics in Cardiac Ischemia/Reperfusion Injury: A Bioinformatics and Experimental Study
Provisionally accepted
- 1The Affiliated Hospital of Guizhou Medical University, Guiyang, China
- 2Guizhou Medical University, Guiyang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
INTRODUCTION Myocardial ischemia/reperfusion injury (MIRI) remains a major global health issue with rising morbidity and mortality. Blood flow restoration can worsen damage to oxygen-deprived cardiac tissue. This research aimed to identify hub genes linked to MIRI across various reperfusion stages, offering potential diagnostic indicators and therapeutic targets. METHODS Differentially expressed genes (DEGs) at 6, 24, and 72 hours post-reperfusion based on the GSE160516 dataset via GEO2R were identified, and these genes were further analyzed using the DAVID database and online platforms for Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and Disease Ontology (DO) enrichment. Protein – protein interaction (PPI) networks were constructed using STRING and visualized with Cytoscape, and the Degree algorithm within the CytoHubba plug-in identified the top ten hub genes at each time point. Additional analyses included miRNA-hub gene prediction, transcription factor-hub gene regulation, and drug-hub gene interactions via miRDB, TRRUST and DGIdb platforms. Receiver operating characteristic (ROC) curve analysis and immune cell infiltration assessment were performed using online analytical tools and CIBERSORT. Finally, an oxygen–glucose deprivation/reperfusion (OGD/R) model in HL-1 mouse cardiomyocytes and external datasets validated the expression of hub genes. RESULTS Totally, 341, 399 and 431 DEGs at 6, 24, and 72 hours post-reperfusion were screened, enriched in functions, such as inflammatory pathways, cytokine-receptor interactions, and immune or inflammatory-related diseases. Degree algorithm analysis identified the top ten hub genes (Il1b, Cxcl2, Cd44, etc.) at 6h, (Il1b, Il6, Fn1, etc.) at 24h and (Fcgr3, Ccl2, Cd68, etc.) at 72h. Most hub genes showed notable interactions with specific microRNAs (mmu-let-7c-1-3p, mmu-miR-466l-3p), the transcription factor Nfkb1, and drugs with the highest drug-gene interaction scores (EMAPTICAP PEGOL, CARLUMAB, Compound 27 [PMID: 19854648]). ROC curve analyses demonstrated high diagnostic potential (AUC 0.889–1.000; sensitivity 100%; specificity 66.67–100%) and immune infiltration analysis indicated increased resting dendritic cells and decreased neutrophils. Validation in HL-1 OGD/R models and external datasets confirmed elevated mRNA expression of Serpine1, Ccl2, Il6, and Fn1 at various reperfusion stages. CONCLUSIONS Analysis across multiple datasets and HL-1 cell experimental models revealed four significantly altered genes—Serpine1, Ccl2, Il6 and Fn1—indicating their potential targets for MIRI.
Keywords: Myocardial ischemia/reperfusion injury, Bioinformatics analysis, Gene Expression Omnibus, Differential expression genes, Hub genes, Enrichment analysis
Received: 18 Jul 2025; Accepted: 30 Oct 2025.
Copyright: © 2025 Zuo, Yang, Qian and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yu Zuo, m15585177007@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.